Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 26S proteasome is a large, multi-protein complex that serves as the primary protease in eukaryotic cells, responsible for regulated protein degradation. It is central to the ubiquitin-proteasome system (UPS), which tags proteins with ubiquitin for selective degradation. This process maintains protein homeostasis and regulates essential cellular processes such as cell cycle progression, DNA replication, transcription, signal transduction, stress responses, and immune surveillance. Malfunction or dysregulation contributes to various diseases including cancer—where it is targeted therapeutically—neurodegenerative disorders due to accumulation of misfolded proteins—and autoimmune diseases due to altered antigen processing/presentation.
Inhibition of proteasome activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S (26S Proteasome).